You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Cannabidiol as a Promising Strategy to Treat and Prevent Movement Disorders?
|
|---|---|
| Published in |
Frontiers in Pharmacology, May 2018
|
| DOI | 10.3389/fphar.2018.00482 |
| Pubmed ID | |
| Authors |
Fernanda F. Peres, Alvaro C. Lima, Jaime E. C. Hallak, José A. Crippa, Regina H. Silva, Vanessa C. Abílio |
| Abstract |
Movement disorders such as Parkinson's disease and dyskinesia are highly debilitating conditions linked to oxidative stress and neurodegeneration. When available, the pharmacological therapies for these disorders are still mainly symptomatic, do not benefit all patients and induce severe side effects. Cannabidiol is a non-psychotomimetic compound from Cannabis sativa that presents antipsychotic, anxiolytic, anti-inflammatory, and neuroprotective effects. Although the studies that investigate the effects of this compound on movement disorders are surprisingly few, cannabidiol emerges as a promising compound to treat and/or prevent them. Here, we review these clinical and pre-clinical studies and draw attention to the potential of cannabidiol in this field. |
X Demographics
The data shown below were collected from the profiles of 43 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 12 | 28% |
| Canada | 3 | 7% |
| Switzerland | 2 | 5% |
| United Kingdom | 2 | 5% |
| Colombia | 2 | 5% |
| Portugal | 2 | 5% |
| France | 1 | 2% |
| Italy | 1 | 2% |
| Ecuador | 1 | 2% |
| Other | 4 | 9% |
| Unknown | 13 | 30% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 36 | 84% |
| Scientists | 4 | 9% |
| Practitioners (doctors, other healthcare professionals) | 2 | 5% |
| Science communicators (journalists, bloggers, editors) | 1 | 2% |
Mendeley readers
The data shown below were compiled from readership statistics for 335 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 335 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 58 | 17% |
| Student > Master | 48 | 14% |
| Researcher | 40 | 12% |
| Student > Ph. D. Student | 28 | 8% |
| Other | 23 | 7% |
| Other | 45 | 13% |
| Unknown | 93 | 28% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 46 | 14% |
| Pharmacology, Toxicology and Pharmaceutical Science | 43 | 13% |
| Biochemistry, Genetics and Molecular Biology | 39 | 12% |
| Agricultural and Biological Sciences | 26 | 8% |
| Neuroscience | 23 | 7% |
| Other | 51 | 15% |
| Unknown | 107 | 32% |
Attention Score in Context
This research output has an Altmetric Attention Score of 78. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 24 October 2023.
All research outputs
#556,211
of 25,758,695 outputs
Outputs from Frontiers in Pharmacology
#207
of 19,997 outputs
Outputs of similar age
#12,176
of 340,477 outputs
Outputs of similar age from Frontiers in Pharmacology
#9
of 413 outputs
Altmetric has tracked 25,758,695 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 97th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 19,997 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.4. This one has done particularly well, scoring higher than 98% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 340,477 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 96% of its contemporaries.
We're also able to compare this research output to 413 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 97% of its contemporaries.